High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection

Infectious Agents and Cancer

Volumn 9, Issue 1, 2014, Pages

  Seraceni, Silva ^a   De Seta, Francesco ^a,b   Colli, Claudia ^c   Del Savio, Rossella ^a   Pesel, Giuliano ^a   Zanin, Valentina ^a   D'Agaro, Pierlanfranco ^a,b   Contini, Carlo ^d   Comar, Manola ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c ASS 1   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chlamydia trachomatis; HPV multiple genotypes; Hsp60 RNA persistent infection; Human papillomavirus

Indexed keywords

CHAPERONIN 60;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE PREDISPOSITION; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; GENOTYPE; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEROTYPE; VIRUS DETECTION;

EID: 84908401789     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-9-30     Document Type: Article

References (38)

1. Mascellino MT, Boccia P, Oliva A: Immunopathogenesis in Chlamydia trachomatis Infected Women. ISRN Obstet Gynecol 2011, 436936:1-9.
2. Malhotra M, Sood S, Mukherjee A, Muralidhar S, Bala M: Genital Chlamydia trachomatis: an update. M Indian J Med Res 2013, 138(3):303-316.
3. Hjelholt A, Christiansen G, Johannesson TG, Ingerslev HJ, Birkelund S: Tubal factor infertility is associated with antibodies against Chlamydia trachomatis heat shock protein 60 (HSP60) but not human HSP60. Hum Reprod 2011, 26(8):2069-2076.
4. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, Ambrosini G, Armanini D: Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 2008, 140(1):3-11.
5. Choroszy-Król IC, Frej-Ma¸drzak M, Jama-Kmiecik A, Bober T, Jolanta Sarowska J: Characteristics of the Chlamydia trachomatis species-immunopathology and infections. Adv Clin Exp Med 2012, 21(6):799-808. Review.
6. Paavonen J: Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med 2012, 44(1):18-28.
7. Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M; IARC HPV Prevalence Surveys Study Group: Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010, 19(2):503-510.
8. Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL: Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 2009, 11(4):435-442.
9. Deluca GD, Basiletti J, Schelover E, Vásquez ND, Alonso JM, Marín HM, Lucero RH, Picconi MA: Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina. Braz J Infect Dis 2011, 15(6):567-572.
10. Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, Iftner T, Kjær SK: Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect 2014, 0:1-6.
11. Tommasino M: The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol 2013, S1044-579X(13):00123-00125.
12. Schimtt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group: Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 2013, 51(5):1458-1464.
13. Bhatla N, Puri K, Joseph E, Kriplani A, Iyer VK, Sreenivas V: Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia - a pilot study. Indian J Med Res 2013, 137(3):533-539.
14. Silva J, Cerqueira F, Medeiros R: Chlamydia trachomatis infection: implications for HPV status and cervical cancer. Arch Gynecol Obstet 2014, 289(4):715-723.
15. Tavares MC, de Macêdo JL, de Lima Júnior SF, de Andrade HS, Amorim MM, de Mascena Diniz Maia M, de Souza PR: Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil. Mol Biol Rep 2014, 1(2):865-874.
16. Shew ML, Ermel AC, Weaver BA, Tong Y, Tu W, Kester LM, Denski C, Fortenberry JD, Brown DR: Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis 2013, 208(9):1416-1421.
17. Contini C, Grilli A, Badia L, Guardigni V, Govoni M, Seraceni S: Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value. Rheumatol Int 2011, 31(10):1307-1313.
18. Contini C, Seraceni S: Chlamydial disease: a crossroad between chronic infection and development of infection. In Bacterial and Cancer. Chapter 4. Switzerland: Springer Science; 2012.
19. Brankatschk R, Bodenhausen N, Zeyer J, Bürgmann H: Simple absolute quantification method correcting for quantitative PCR efficiency variations for microbial community samples. Appl Environ Microbiol 2012, 78(12):4481-4489.
20. Contini C, Seraceni S, Maritati M, Cavazzini F, Perri P: Role of Chlamydia in the Development of Ocular Adnexal Lymphoma. J Cancer Ther 2013, 4:662-677.
21. Comar M, Iannacone MR, Casalicchio G, McKay-Chopin S, Tommasino M, Gheit T: Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. J Clin Microbiol 2012, 50(12):4041-4046.
22. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M: Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006, 44(6):2025-2031.
23. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N, Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
24. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 2009, 125:2151-2158.
25. Carozzi F, Ronco G, Gillio-Tos A, De Marco L, Del Mistro A, Girlando S, Franceschi S, Plummer M, Vaccarella S: New Technologies for Cervical Cancer Screening (NTCC) Working Group. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012, 48:1633-1637.
26. Chaturvedi AK, Katki HA, Hildesheim A, Rodriguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R, CVT Group: Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203:910-920.
27. Rositch AF, Poole C, Hudgens MG, Agot K, Nyagaya E, Moses S, Snijders PJ, Meijer CJ, Bailey RC, Smith JS: Multiple human papillomavirus infections and type competition in men. J Infect Dis 2012, 205:72-81.
28. Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, Hildesheim A, Burk RD, Plummer M: Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011, 204:385-390.
29. Vaccarella S, Plummer M, Franceschi S, Gravitt P, Papenfuss M, Smith D, Villa L, Ponce EL, Giuliano AR: Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study. J Infect Dis 2011, 204:1500-1504.
30. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B: One virus, one lesion-individual components of CIN lesions contain a specific HPV type. J Pathol 2012, 227:62-71.
31. Comar M, Monasta L, Zanotta N, Vecchi Brumatti L, Ricci G, Zauli G: Human papillomavirus infection is associated with decreased levels of GM-CSF in cervico-vaginal fluid of infected women. J Clin Virol 2013, 58(2):479-481.
32. Sammarco ML, Del Riccio I, Tamburro M, Grasso GM, Ripabelli G: Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy. Eur J Obstet Gynecol Reprod Biol 2013, 168(2):222-226.
33. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E: Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004, 57:68-72.
34. Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G, NTCC Working Group: Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol 2014, 60(3):257-263.
35. Giorgi Rossi P, Chini F, Bisanzi S, Burroni E, Carillo G, Lattanzi A, Angeloni C, Scalisi A, Macis R, Pini MT, Capparucci P, Guasticchi G, Carozzi FM, Prevalence Italian Working Group.HPV: Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infect Agent Cancer 2011, 20(6):2-8.
36. Gérard HC, Carter JD, Hudson AP: Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci 2013, 346(1):22-25.
37. Dean D, Kandel RP, Adhikari HK, Hessel T: Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Med 2008, 5(1):e14.
38. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ: Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog 2009, 5(8):e1000552.